Posted by Michael Wonder on 16 Dec 2021
Patient reported endpoints underrepresented in product information on new drugs
15 December 2021 - An IQWiG team analysed the extent to which patient reported outcomes, which were recorded as endpoints in clinical studies on new drugs, are reported in product information.
Before a new active ingredient comes onto the market, the manufacturer must submit a Summary of Product Characteristics for approval.
